Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALGeneric

ANDRODERM

TESTOSTERONE

Standard Dose
2.5MG/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ANDRODERM is listed in Drugs@FDA under application 020489 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 2.5MG/24HR Sponsor ABBVIE Submission history Latest submission status date: 2020-05-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview ANDRODERM is listed in Drugs@FDA under application 020489 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 2.5MG/24HR Sponsor ABBVIE Submission history Latest submission status date: 2020-05-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.